Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Consort Medical PLC

17 Jan 2020 11:13

RNS Number : 1865A
Polar Capital Holdings PLC
17 January 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Polar Capital LLP, the Investment Manager, disclosing on behalf of:

 

Polar Capital Funds PLC - Healthcare Opportunities Fund

 

Polar Capital Global Healthcare Trust PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Consort Medical Plc

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2020-01-16

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,647,159

7.38

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

3,647,159

7.38

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10 GBp Ordinary

Sale

3053

1030

10 GBp Ordinary

Sale

17,759

1030

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

2020-01-17

Contact name:

Paddy Drewett

Telephone number*:

+44 (0) 20 7227 3058

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETEAFFXFFEEEFA
Date   Source Headline
21st Aug 20061:08 pmRNSDirector/PDMR Shareholding
18th Aug 200610:08 amRNSAnnual Information Update
16th Aug 200610:07 amRNSDirector/PDMR Shareholding
11th Aug 20065:22 pmRNSHolding(s) in Company
4th Aug 20064:11 pmRNSDirector/PDMR Shareholding
3rd Aug 20067:01 amRNSDisposal
28th Jul 20062:44 pmRNSHolding(s) in Company
27th Jul 20067:03 amRNSDirectorate Change
25th Jul 200611:06 amRNSBlocklisting
14th Jul 20069:41 amRNSHolding(s) in Company
13th Jul 20065:42 pmRNSDirector/PDMR Shareholding
12th Jul 20067:01 amRNSFinal Results
30th Jun 20062:46 pmRNSHolding(s) in Company
28th Jun 20064:15 pmRNSHolding(s) in Company
20th Jun 20069:49 amRNSFacility Visit
2nd Jun 20069:00 amRNSDirectorate Change
30th May 20064:30 pmRNSHolding(s) in Company
22nd May 20064:03 pmRNSHolding(s) in Company
12th May 20061:19 pmRNSDirector/PDMR Shareholding
11th May 20063:51 pmRNSSubstantial Shareholding
10th May 200610:24 amRNSPDMR Share Purchase
3rd May 20067:01 amRNSTrading Update
2nd May 20064:58 pmRNSDirector's Shareholding
2nd May 20067:01 amRNSBlocklisting
26th Apr 200612:02 pmRNSChairman's Share Purchase
26th Apr 200611:31 amRNSBoard Changes
25th Apr 20067:01 amRNSBlocklisting
24th Apr 20064:15 pmRNSBlocklisting
24th Apr 20062:00 pmRNSNext Generation Inhaler
19th Apr 20063:15 pmRNSSubstantial Shareholding
4th Apr 200611:22 amRNSSubstantial Shareholding
30th Mar 20067:01 amRNSBlock Listing 6 Months Review
27th Mar 20067:01 amRNSDirector/PDMR Shareholding
14th Mar 20069:24 amRNSDirector Share Purchase
9th Mar 20067:01 amRNSCompany Secretary Change
6th Feb 200610:07 amRNSDirector/PDMR Shareholding
30th Jan 20067:01 amRNSExubera Approval in US
27th Jan 200612:23 pmRNSDirector/PDMR Shareholding
27th Jan 20067:01 amRNSExubera Regulatory Approval
24th Jan 200610:08 amRNSBlocklisting Six Month Return
18th Jan 20067:00 amRNSInterim Results
13th Jan 20067:01 amRNSAdoption of IFRS
10th Jan 200610:04 amRNSDirector/PDMR Shareholding
6th Jan 20065:49 pmRNSHolding(s) in Company
4th Jan 20062:41 pmRNSNotification of Shares
4th Jan 20062:39 pmRNSNotification of Shares
4th Jan 20069:16 amRNSNotice of Results
23rd Dec 20057:01 amRNSAcquisition & Blocklisting
22nd Dec 200510:28 amRNSResult of EGM
8th Dec 20055:17 pmRNSDIRECTOR/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.